|
[1]
|
Jemal A, Siegel R, Xu J, et al. Cancer statistics 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300. doi: 10.3322/caac.20073
|
|
[2]
|
张思维, 雷正龙, 李光琳, 等. 中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J]. 中国肿瘤, 2010, 19(6): 356-365. doi: 10.3969/j.issn.1674-4136.2013.06.005
|
|
[3]
|
Khatri VP, Petrelli NJ, Belghiti J. Extending the frontiers of surgical therapy for hepatic colorectal metastases: is there a limit?[J]. J Clin Oncol, 2005, 23(33): 8490-8499. doi: 10.1200/JCO.2004.00.6155
|
|
[4]
|
Imamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years[J]. 2003, 138(11): 1198-1206. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM14609867
|
|
[5]
|
Misiakos EP, Karidis NP, Kouraklis G. Current treatment for colorectal liver metastases[J]. World J Gastroenterol, 2011, 17(36): 4067-4075. doi: 10.3748/wjg.v17.i36.4067
|
|
[6]
|
Figueras J, Torras J, Valls C, et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients[J]. Dis Colon Rectum, 2007, 50(4): 478-488. doi: 10.1007/s10350-006-0817-6
|
|
[7]
|
Nordlinger B, Guiguet M, Vaillant JC, et al. Surgical resection of colorectal carcinoma metastases to the liver. a prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie[J]. Cancer, 1996, 77(7): 1253-1262. http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM8608500
|
|
[8]
|
Bismuth H, Castaing D, Traynor O. Surgery for synchronous hepatic metastases of colorectal cancer[J]. Scand J Gastroenterol Suppl, 1988, 149: 144-149. https://pubmed.ncbi.nlm.nih.gov/3201153/
|
|
[9]
|
Bolton JS, Fuhrman GM. Survival after resection of multiple bilobar hepatic metastases from colorectal carcinoma[J]. Annals of Surgery, 2000, 231(5): 743-751. doi: 10.1097/00000658-200005000-00015
|
|
[10]
|
Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis[J]. J Am Coll Surg, 2003, 197(2): 233-241. doi: 10.1016/S1072-7515(03)00390-9
|
|
[11]
|
Brouquet A, Mortenson MM, Vauthey JN, et al. Surgical strategies for synchronous colorectal liver metastases in 156 consecutive patients: classic, combined or reverse strategy[J]? J Am Coll Surg, 2010, 210(6): 934-941. doi: 10.1016/j.jamcollsurg.2010.02.039
|
|
[12]
|
Martin RC 2nd, Augenstein V, Reuter NP, et al. Simultaneous versus staged resection for synchronous colorectal cancer liver metastases[J]. 2009, 208(5): 842-850.
|
|
[13]
|
Brouquet A, Nordlinger B. Neoadjuvant therapy of colorectal liver metastases: lessons learned from clinical trials[J]. J Surg Oncol. 2010, 102(8): 932-936. doi: 10.1002/jso.21657
|
|
[14]
|
Lehmann K, Rickenbacher A, Weber A, et al. Chemotherapy before liver resection of colorectal metastases : friend or foe?[J]. Ann Surg, 2012, 255(2): 237-247. doi: 10.1097/SLA.0b013e3182356236
|
|
[15]
|
Bosset JF, Collette L, Calais G, et al. Chemotherapy with preoperative radiotherapy in rectal cancer[J]. N Engl J Med, 2006, 355(11): 1114-1123. doi: 10.1056/NEJMoa060829
|
|
[16]
|
Cleary JM, Tanabe KT, Lauwers GY, et al. Hepatic toxicities associated with the use of preoperative systemic therapy in patients with metastatic colorectal adenocarcinoma to the liver[J]. Oncologist, 2009, 14(1): 1095-1105 http://med.wanfangdata.com.cn/Paper/Detail/PeriodicalPaper_PM19880627
|
|
[17]
|
Power DG, Kemeny NE. Role of adjuvant therapy after resection of colorectal cancer liver metastases[J]. J Clin Oncol, 2010, 28(13): 2300-2309. doi: 10.1200/JCO.2009.26.9340
|
|
[18]
|
Ychou M, Hohenberger W, Thezenas S, et al. A randomized phase Ⅲ study comparing adjuvant 5-fluorouracil/folinic acid with FOLFIRI in patients following complete resection of liver metastases from colorectal cancer[J]. Ann Oncol, 2009, 20(12): 1964-1970. doi: 10.1093/annonc/mdp236
|
|
[19]
|
Kishi Y, Abdalla EK, Chun YS, et al. Three hundred and one consecutive extended right hepatectomies: evaluation of outcome based on systematic liver volumetry[J]. Ann Surg, 2009, 250(4): 540-548. doi: 10.1097/SLA.0b013e3181b674df
|
|
[20]
|
Sharma S, Camci C, Jabbour N. Management of hepatic metastasis from colorectal cancers: an update[J]. J Hepatobiliary Pancreat Surg, 2008, 15(6): 570-580. doi: 10.1007/s00534-008-1350-x
|
|
[21]
|
Ismaili N. Treatment of colorectal liver metastases[J]. World J Surg Oncol, 2011, 9: 154-165. doi: 10.1186/1477-7819-9-154
|
|
[22]
|
Jianmin Xu, Xinyu Qin, Jianping Wang, et al. Chinese guidelines for the diagnosis and comprehensive treatment of hepatic metastasis of colorectal cancer[J]. J Cancer Res Clin Oncol, 2011, 137(9): 1379-1396. doi: 10.1007/s00432-011-0999-8
|
|
[23]
|
Falcone A, Ricci S, Brunetti I, et al. Phase Ⅲ trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as frst-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest[J]. J Clin Oncol, 2007, 25(13): 1670-1676. doi: 10.1200/JCO.2006.09.0928
|
|
[24]
|
Ammori JB, D'Angelica MI, Fong Y, et al. Hepatic artery infusional chemotherapy in patients with unresectable colorectal liver metastases and extrahepatic disease[J]. J Surg Oncol, 2012, 106(8): 953-958. doi: 10.1002/jso.23204
|
|
[25]
|
Kingham TP, D'Angelica M, Kemeny NE. Role of intra-arterial hepatic chemotherapy in the treatment of colorectal cancer metastases [J]. J Surg Oncol, 2010, 102(8): 988-995. doi: 10.1002/jso.21753
|
|
[26]
|
Mocellin S, Pasquali S, Nitti D (2009) Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer[J]. Cochrane Database Syst Rev 4: CD007823. https://pubmed.ncbi.nlm.nih.gov/19588444/
|
|
[27]
|
Zdenkowski N, Chen S, van der Westhuizen A, et al. Curative strategies for liver metastases from colorectal cancer: a review[J]. Oncologist, 2012, 17(2): 201-211. doi: 10.1634/theoncologist.2011-0300
|
|
[28]
|
Madoff DC, Abdalla EK, Vauthey JN. Portal vein embolization in preparation for major hepatic resection: evolution of a new standard of care[J]. J Vasc Interv Radiol, 2005, 16(6): 779-790. doi: 10.1097/01.RVI.0000159543.28222.73
|
|
[29]
|
Schnitzbauer AA, Lang SA, Goessmann H, et al. Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings[J]. Ann Surg, 2012, 255(3): 405-414. doi: 10.1097/SLA.0b013e31824856f5
|
|
[30]
|
Wong SL, Mangu PB, Choti MA, et al. American Society of Clinical Oncology 2009 clinical evidence review on radiofrequency ablation of hepaticmetastases from colorectal cancer[J]. J Clin Oncol, 2010, 28(3): 493-508. doi: 10.1200/JCO.2009.23.4450
|
|
[31]
|
Abdalla EK, Vauthey JN, Ellis LM, et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases[J]. Ann Surg, 2004, 239(6): 818-825. doi: 10.1097/01.sla.0000128305.90650.71
|
点击查看大图
下载:
